InsiderFlow

Thomas D. Carey

LAB

Thomas D. Carey serves as director at Standard BioTools Inc. (LAB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$46.9K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$46.9K

Companies Traded

1

LAB

Active Period

Nov 2026

1 total trades

Most Recent

Buy LAB

Nov 5, 2026 · $46.9K

Thomas D. Carey's Insider Trading at Standard BioTools Inc. (LAB)

Buys

1 · $46.9K

Sells

0 · $0.00

Total Shares Bought

75,000

Total Shares Sold

0

LAB Price Chart
Loading chart...
DateTypeValue
Nov 5, 2026 Buy$46.9K